Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.3969
+0.0038 (0.97%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $16.50 million as of April 25, 2025. Its market cap has decreased by -78.79% in one year.
Market Cap
16.50M
Enterprise Value
-30.48M
1-Year Change
-78.79%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $16.50M, a decrease of -77.64%. That is a compound annual growth rate of -16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 16.50M | -85.03% |
| Dec 31, 2024 | 110.20M | 3.96% |
| Dec 29, 2023 | 106.00M | 137.67% |
| Dec 30, 2022 | 44.60M | -84.42% |
| Dec 31, 2021 | 286.20M | 113.26% |
| Dec 31, 2020 | 134.20M | 395.20% |
| Dec 31, 2019 | 27.10M | -7.82% |
| Dec 31, 2018 | 29.40M | -49.83% |
| Dec 29, 2017 | 58.60M | -20.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |